“deerfield-capital” Archives

in
Entry Author Date Location
Homology Medicines Obtains $43,500,000 Series A Round 05/03/16 Boston
GrayBug Vision Receives $44,500,000 Series B Funding 05/02/16 San Francisco
Lumos Pharma Receives $34,000,000 Series B Round 04/06/16 Texas
Acutus Medical Secures $75,000,000 Series C Financing Round 03/22/16 San Diego
Synlogic Obtains $40,000,000 Series B Round 02/17/16 Boston
Syros Pharmaceuticals Garners $40,000,000 New Financing 01/13/16 Boston
Xeris Pharmaceuticals Secures $41,000,000 Series C Funding Round 01/12/16 Texas
Hallux Garners $7,100,000 Series A Funding Round 12/18/15 San Diego
Fractyl Laboratories Garners $57,000,000 Series C Funding Round 11/19/15 Boston
Audentes Therapeutics Garners $65,000,000 Series C Funding 10/14/15 San Francisco
Akari Therapeutics Receives New Round 09/22/15 New York
AveXis Obtains $65,000,000 Series D Round 09/09/15 Texas
Editas Medicine Garners $120,000,000 New Funding 08/10/15 Boston
Auspex Pharmaceuticals Lands $20,000,000 Series E Financing 01/08/14 San Diego
Trivascular Obtains $40,000,000 Series E Funding Round 11/18/13 San Francisco
Practice Fusion Lands $70,000,000 Series D Round 09/24/13 San Francisco
Dicerna Pharmaceuticals Obtains $60,000,000 Series C Funding 08/01/13 Boston
WorldOne Research Lands $35,000,000 New Funding Round 04/03/13 New York
Foundation Medicine Secures $42,500,000 Series B Financing 09/21/12 Boston
bluebird bio Garners $60,000,000 Series D Funding Round 07/25/12 Boston
Tesaro Garners $101,000,000 Series B Financing Round 06/21/11 Boston
Page 1 of 1